Yousef, R., M. R. Salem, and A. Taher, "Impact of implementation of a modified World Health Organization multimodal hand hygiene strategy in a university teaching hospital", American Journal of infection control, vol. 48, issue 3, pp. 249-254, 2020.
Rosenthal, V. D., D. Gupta, P. Rajhans, S. N. Myatra, S. Muralidharan, Y. Mehta, M. Kharbanda, C. Rodrigues, A. Dwivedy, S. Shah, et al., "Six-year multicenter study on short-term peripheral venous catheters-related bloodstream infection rates in 204 intensive care units of 57 hospitals in 19 cities of India: International Nosocomial Infection Control Consortium (INICC) findings.", American journal of infection control, vol. 48, issue 9, pp. 1001-1008, 2020. Abstract

BACKGROUND: Short-term peripheral venous catheters-related bloodstream infections (PVCR-BSIs) rates have not been systematically studied in developing countries, and data on their incidence by number of device-days are not available.

METHODS: Prospective, surveillance study on PVCR-BSI conducted from September 1, 2013 to May 31, 2019 in 204 intensive care units (ICUs), members of the International Nosocomial Infection Control Consortium (INICC), from 57 hospitals in 19 cities of India. We applied US INICC definition criteria and reported methods using the INICC Surveillance Online System.

RESULTS: We followed 7,513 ICU patients for 296,893 bed-days and 295,795 short term peripheral venous catheter (PVC)-days. We identified 863 PVCR-BSIs, amounting to a rate of 2.91/1,000 PVC-days. Mortality in patients with PVC but without PVCR-BSI was 4.14%, and 11.59% in patients with PVCR-BSI. The length of stay in patients with PVC but without PVCR-BSI was 4.13 days, and 5.9 days in patients with PVCR-BSI. The micro-organism profile showed 68% of gram negative bacteria: Escherichia coli (23%), Klebsiella spp (15%), Pseudomonas aeruginosa (5%), and others. The predominant gram-positive bacteria were Staphylococcus aureus (10%).

CONCLUSIONS: PVCR-BSI rates found in our ICUs were much higher than rates published from industrialized countries. Infection prevention programs must be implemented to reduce the incidence of PVCR-BSIs.

Yousef, R. H., N. Elrashidi, sahar khairat, M. Gaafar, M. E. Nady, M. balah, and N. soiiman, "Detection of Mycobacterium tuberculosis and drug resistance by GeneXpert® MTB/RIF and Anyplex™ II MTB/MDR in a tertiary care hospital", Medical sciences, vol. 24, issue 105, pp. 3003-3011, 2020.
NAWAR, N. A. D. A., E. Behiry, R. Yousef, and M. Emara, Application of High-Resolution Melting PCR to Detect the Genomic Fungal ITS 2 Region, , 2019.
Kamal, Y., M. Kandil, M. Eissa, and R. Yousef, "Probiotics as a prophylaxis to prevent oral candidiasis in patients with Sjogren's syndrome: a double-blind, placebo-controlled, randomized trial", Rheumatology international , vol. 20, pp. 873-879, 2020.
Rosenthal, V. D., D. G. Maki, Y. Mehta, H. Leblebicioglu, Z. A. Memish, H. H. Al-Mousa, H. Balkhy, B. Hu, C. Alvarez-Moreno, E. A. Medeiros, et al., "International Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module.", American journal of infection control, vol. 42, issue 9, pp. 942-56, 2014 Sep. Abstract

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line-associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN.

Tourism